Patents by Inventor Simon Lemaire

Simon Lemaire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11199823
    Abstract: Systems and methods for automated management of buildings and rooms employ a common set of components that may be paired together to form a modular room control interface. The components may comprise a base plate and a front plate that are in data communication with each other when connected together. The base plate may include one set of room monitoring and control functions and the front plate may include a different set of room monitoring and control functions. Different combinations of base plates and front plates may then be paired together to achieve a desired functionality in the modular room control interface. Such an arrangement provides a room control interface that can be quickly and easily configured for any number of different room monitoring and control functions as needed.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: December 14, 2021
    Assignee: Schneider Electric Buildings, LLC
    Inventors: Michael Morley, Babak Haghayeghi, Simon Lemaire
  • Patent number: 11131970
    Abstract: Systems and methods for automated management of buildings and rooms employ a common set of components that may be paired together to form a modular room control interface. The components may comprise a base plate and a front plate that are in data communication with each other when connected together. The base plate may include one set of room monitoring and control functions and the front plate may include a different set of room monitoring and control functions. Different combinations of base plates and front plates may then be paired together to achieve a desired functionality in the modular room control interface. Such an arrangement provides a room control interface that can be quickly and easily configured for any number of different room monitoring and control functions as needed.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: September 28, 2021
    Assignee: Schneider Electric Buildings, LLC
    Inventors: Michael Morley, Babak Haghayeghi, Simon Lemaire
  • Publication number: 20190196432
    Abstract: Systems and methods for automated management of buildings and rooms employ a common set of components that may be paired together to form a modular room control interface. The components may comprise a base plate and a front plate that are in data communication with each other when connected together. The base plate may include one set of room monitoring and control functions and the front plate may include a different set of room monitoring and control functions. Different combinations of base plates and front plates may then be paired together to achieve a desired functionality in the modular room control interface. Such an arrangement provides a room control interface that can be quickly and easily configured for any number of different room monitoring and control functions as needed.
    Type: Application
    Filed: December 22, 2017
    Publication date: June 27, 2019
    Applicant: Schneider Electric Buildings LLC
    Inventors: Michael Morley, Babak Haghayeghi, Simon Lemaire
  • Publication number: 20090124555
    Abstract: The invention relates to the use of Histogranin-like compounds to reduce P2X7 (also designed P2Z) receptor function. The invention also provides a method for the prevention and treatment of rheumatoid arthritis and a variety of diseases/disorders including inflammatory disorders and neurodegenerative diseases.
    Type: Application
    Filed: August 23, 2006
    Publication date: May 14, 2009
    Inventors: Irma Bernatchez-Lemaire, Simon Lemaire
  • Patent number: 7183279
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: February 27, 2007
    Assignee: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Publication number: 20060252673
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Application
    Filed: May 25, 2006
    Publication date: November 9, 2006
    Applicant: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Patent number: 7074786
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: July 11, 2006
    Assignee: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Patent number: 6972281
    Abstract: The invention relates to new basic amino acid derivatives of general formula I and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: December 6, 2005
    Assignee: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Publication number: 20050233953
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Application
    Filed: March 14, 2005
    Publication date: October 20, 2005
    Applicant: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Patent number: 6855692
    Abstract: The invention relates to linear and cyclic peptide and pseudopeptide compounds useful as analgesics, pharmaceutical compositions comprising such compounds, the use of the compounds and the compositions in the treatment of pain, and commercial packages containing such compounds and compositions.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: February 15, 2005
    Assignee: University of Ottawa
    Inventor: Simon Lemaire
  • Publication number: 20040006013
    Abstract: The invention relates to linear and cyclic peptide and pseudopeptide compounds useful as analgesics, pharmaceutical compositions comprising such compounds, the use of the compounds and the compositions in the treatment of pain, and commercial packages containing such compounds and compositions.
    Type: Application
    Filed: May 14, 2003
    Publication date: January 8, 2004
    Inventor: Simon Lemaire
  • Publication number: 20030176329
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Application
    Filed: February 7, 2002
    Publication date: September 18, 2003
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Patent number: 6566327
    Abstract: The invention relates to linear and cyclic peptide and pseudopeptide compounds useful as analgesics, pharmaceutical compositions comprising such compounds, the use of the compounds and the compositions in the treatment of pain, and commercial packages containing such compounds and compositions.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: May 20, 2003
    Assignee: University of Ottawa
    Inventor: Simon Lemaire
  • Patent number: 5955493
    Abstract: The present invention relates to morphinan derivatives that are neuroprotective against excitatory amino acid (EAA) cytotoxicity. In particular, morphinan derivatives of the invention act as antagonists at the ionotropic NMDA (N-methyl-(D)-aspartic acid) receptor and are useful as protective agents against peripheral and central nervous system NMDA-receptor mediated toxicity and convulsions.
    Type: Grant
    Filed: April 30, 1998
    Date of Patent: September 21, 1999
    Assignee: Biochem Pharma, Inc.
    Inventor: Simon Lemaire